Sex-associated Risk Factors for Co-infection with Chlamydia trachomatis and Neisseria gonorrhoea among Patients Presenting to a Sexually Transmitted Infection Clinic
DOI:
https://doi.org/10.2340/00015555-3721Keywords:
chlamydia, gonorrhoea, co-infectionAbstract
The aim of this study was to investigate the characteristics of patients co-infected with Chlamydia trachomatis and Neisseria gonorrhoea. A retrospective case-control study was performed, which included 399 co-infected patients seen at a sexually transmitted infection clinic in Copenhagen, Denmark. Case-control groups included 300 patients who tested positive only for N. gonorrhoea, 300 who tested positive only for C. trachomatis, and 300 who tested negative for both N. gonorrhoea and C. trachomatis in the same study period. For men, non-Danish origin (odds ratio (OR) 2.3, 95% confidence interval (Cl) 1.34–4.12), previous sexually transmitted infections with C . trachomatis (OR 3.3, 95% CI 1.94–5.92) and N. gonorrhoea (OR 10.6, 95% CI 6.36-17.76), and higher number of sex partners (OR 1.7, 95% Cl 1.40-2.28) were significantly associated with diagnosis of co-infection. For women, previous sexually transmitted infections with C. trachomatis (OR 6.7, 95% CI 3.89-11.78) and N. gonorrhoea (OR 10.4, 95% CI 4.99-21.71), and higher number of sex partners (OR 1.8, 95% CI 1.28-2.56) were significantly associated with a diagnosis of co-infection, whereas being of non-Danish origin was, in some cases, a protective factor (OR 0.3, 95% CI 0.17-0.69). Furthermore, this study demonstrated sex-associated characteristics that should raise concern about co- infection, including: for men, being of non-Danish origin, men who have sex with men status, and higher age, and, for women, young age, in particular, and previous sexually transmitted infections.
Downloads
References
Danish Health Authority. Sexual health. Presentation of only with condom campaign 2018 rapport. Data accessed November. 02. 2019. The original is in Danish Available from: DOI: https://sund-by-net.dk/wp-content/uploads/2018/03/Præsentation-af-Kun-med-kondom-kampagnen.pdf.
Centers for Disease Control and Prevention. Pelvic inflammatory disease: 2015 STD treatment guidelines. Data accessed November 02. 2019. Available from: DOI: https://www.cdc.gov/std/tg2015/pid.htm.
Davies B, Turner KME, Frølund M, Ward H, May MT, Rasmussen S, et al. Danish Chlamydia Study Group. Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. Lancet Infect Dis 2016; 16: 1057-1064.
DOI: https://doi.org/10.1016/S1473-3099(16)30092-5
Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases: United States recommendations of the Advisory Committee for HIV and STD Prevention. MMWR Morb Mortal Wkly Rep 1998; 47: 1-24.
Peterman TA, Tian LH, Metcalf CA, Satterwhite CL, Malotte CK, Deaugustine N, et al. RESPECT-2 study group. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006; 145: 564-572.
DOI: https://doi.org/10.7326/0003-4819-145-8-200610170-00005
Hsu KK, Molotnikov LE, Roosevelt KA, Elder HR, Klevens RM, DeMaria JR A, et al. Characteristics of cases with repeated sexually transmitted infections, Massachusetts, 2014-2016. Clin Infect Dis 2018; 67: 99-104.
DOI: https://doi.org/10.1093/cid/ciy029
Hosenfeld CB, Workowski KA, Berman S, Zaidi A, Dyson J, Mosure D, et al. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 2009; 36: 478-489.
DOI: https://doi.org/10.1097/OLQ.0b013e3181a2a933
Tapsall JW, Kinchington M. The frequency of co-infection with Neisseria gonorrhoeae and Chlamydia trachomatis in men and women in eastern Sydney. Clin Infect Dis 2018; 67: 99-104.
Sexually transmitted diseases treatment guidelines 1982. MMWR Morb Mortal Wkly Rep 1982; 31 Suppl 2: 33S-60S.
Das S, Allan PS, Wade AAH. A retrospective study of the clinical effectiveness of the treatment of genital co-infection with N. gonorrhoeae and C. trachomatis in Coventry. Int J STD AIDS 2002; 13: 178-180.
DOI: https://doi.org/10.1258/0956462021924875
Creighton S, Tenant-Flowers M, Taylor CB, Miller R, Low N. Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean? Int J STD AIDS 2003; 14: 109-113.
DOI: https://doi.org/10.1258/095646203321156872
Woolfit JM, Watt L. Chlamydia infection of the uro-genital tract in promiscuous and non-promiscuous women. Br J Vener Dis 1977; 53: 93-95.
DOI: https://doi.org/10.1136/sti.53.2.93
Lycke E, Lowhagen GB, Hallhagen G, Johannisson G, Ramstedt K. The risk of transmission of genital chlamydia trachomatis infection is less than that of neisseria gonorrhoeae infection. Sex Transm Dis 1980; 7: 6-10.
DOI: https://doi.org/10.1097/00007435-198001000-00002
Mårdh PA, Lind I, From E, Andersen AL. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections in Greenland. Br J Vener Dis 1980; 56: 327-331.
DOI: https://doi.org/10.1136/sti.56.5.327
Rose SB, Garrett SM, Stanley J, Pullon SRH. Retesting and repeat positivity following diagnosis of chlamydia trachomatis and neisseria gonorrhoea in New Zealand: a retrospective cohort study. BMC Infect Dis 2017; 17: 526.
DOI: https://doi.org/10.1186/s12879-017-2635-y
Trecker MA, Dillon J-AR, Lloyd K, Hennink M, Jolly A, Waldner C. Can social network analysis help address the high rates of bacterial sexually transmitted infections in Saskatchewan? Sex Transm Dis 2017; 44: 338-343.
DOI: https://doi.org/10.1097/OLQ.0000000000000599
Trecker MA, Dillon JAR, Lloyd K, Hennink M, Waldner CL. Demographic and behavioural characteristics predict bacterial STI reinfection and coinfection among a cross-sectional sample of laboratory-confirmed gonorrhea cases in a local health region from Saskatchewan, Canada. Can J Public Heal 2015; 106: e17-21.
DOI: https://doi.org/10.17269/CJPH.106.4792
Oh MK, Smith KR, O'Cain M, Kilmer D, Johnson J, Hook EW 3rd. Urine-based screening of adolescents in detention to guide treatment for gonococcal and chlamydial infections. Translating research into intervention. Arch Pediatr Adolesc Med 1998; 152: 52-56.
DOI: https://doi.org/10.1001/archpedi.152.1.52
Zhang J, Van Der Veen S. Neisseria gonorrhoeae 23S rRNA A2059G mutation is the only determinant necessary for high-level azithromycin resistance and improves in vivo biological fit- ness. J Antimicrob Chemother 2019; 74: 407-415.
DOI: https://doi.org/10.1093/jac/dky438
Hillis SD, Nakashima A, Marchbanks PA, Addiss DG, Davis JP. Risk factors for recurrent Chlamydia trachomatis infections in women. Am J Obstet Gynecol Mosby 1994; 170: 801-806.
DOI: https://doi.org/10.1016/S0002-9378(94)70286-1
Leonard CA, Schoborg RV, Low N, Unemo M, Borel N. Pathogenic interplay between chlamydia trachomatis and neisseria gonorrhoeae that influences management and control efforts - more questions than answers? Curr Clin Micro Rpt 2019; 6: 182-191.
DOI: https://doi.org/10.1007/s40588-019-00125-4
Raifman JR, Gebo KA, Mathews WC, Korthuis PT, Ghanem KG, Aberg JA, et al. HIV Research Network. Gonorrhea and chlamydia case detection increased when testing increased in a multisite US HIV Cohort, 2004-2014. J Acquir Immune Defic Syndr 2017; 76: 409-416.
DOI: https://doi.org/10.1097/QAI.0000000000001514
Health Resources and Services Administration, Administration Services, HIV Medicine Association of the Infectious Diseases Society of America others. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Reports Centers Dis Control 2003; 52 (RR-12): 1.
The State Serum Institute (SSI) in Denmark. Syphilis report 2017. Danish. Statens Serum Institut. EPI-NYT 2018; 22. Data accessed November. 02. 2019. The original is in Danish. Available from: DOI: https://www.ssi.dk/aktuelt/nyhedsbreve/epi-nyt/2018/uge-22---2018.
Burchell AN, Grewal R, Allen VG, Gardner SL, Moravan V, Bayoumi AM, et al. Modest rise in chlamydia and gonorrhoea testing did not increase case detection in a clinical HIV cohort in Ontario, Canada. Sex Transm Infect 2014; 90: 608-614.
DOI: https://doi.org/10.1136/sextrans-2014-051647
Hoover KW, Butler M, Workowski K, Carpio F, Follansbee S, Gratzer B, et al. STD screening of HIV-infected MSM in HIV clinics. Sex Transm Dis 2010; 37: 771-776.
DOI: https://doi.org/10.1097/OLQ.0b013e3181e50058
Rieg G, Lewis RJ, Miller LG, Witt MD, Guerrero M, Daar ES. Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies. AIDS Patient Care STDS 2008; 22: 947-954.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Farnam Barati Sedeh, Simon F. Thomsen, Helle K. Larsen, Henrik Westh, Kirsten Salado-Rasmussen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
